MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
2.59 M |
Marktkapitalisierung |
$ 19.4 M |
EBITDA (LTM) |
$ -11.3 M |
P/E (LTM) |
- |
P/S (LTM) |
147.99416 |
EPS (LTM) |
-5.35 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
VolitionRx Limited
VNRX
|
$ 0.17 | 2.96 % | $ 21.4 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 453.67 | -0.48 % | $ 27 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 7.27 | -2.81 % | $ 157 M | Nasdaq Global Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
Castle Biosciences
CSTL
|
$ 33.08 | -0.33 % | $ 959 M | Nasdaq Global Market,SPB | USA |
 |
DexCom
DXCM
|
$ 77.94 | -0.49 % | $ 30.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 20.1 | 0.55 % | $ 619 M | Nasdaq Global Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 670.29 | -0.92 % | $ 34.4 B | NYSE,SPB | Schweiz |
 |
National Research Corporation
NRC
|
$ 21.93 | 2.57 % | $ 491 M | Nasdaq Global Select Market | USA |
 |
Sotera Health Company
SHC
|
$ 18.1 | -0.17 % | $ 5.14 B | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 403.95 | 0.64 % | $ 55.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Twist Bioscience Corporation
TWST
|
$ 139.92 | 3.28 % | $ 8.37 B | Nasdaq Global Select Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 241.89 | -0.57 % | $ 26.8 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 560.38 | -1.13 % | $ 45.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 15.85 | 0.19 % | $ 1.41 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 13.73 | 1.85 % | $ 578 M | Nasdaq Global Select Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 6.47 | 2.11 % | $ 28.6 M | Nasdaq Global Select Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Biomerica
BMRA
|
$ 1.68 | 2.32 % | $ 4.9 M | Nasdaq Capital Market | USA |
 |
Myriad Genetics
MYGN
|
$ 5.82 | 1.04 % | $ 539 M | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.11 | 2.43 % | $ 633 M | Nasdaq Global Select Market,SPB | USA |
 |
Neuronetics
STIM
|
$ 2.11 | 1.44 % | $ 139 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 173.07 | -0.52 % | $ 49.2 B | NYSE,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 345.37 | 1.69 % | $ 17.1 B | NYSE,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Guardant Health
GH
|
$ 169.08 | 3.77 % | $ 21.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.99 | 7.55 % | $ 97 K | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 185.27 | -0.09 % | $ 14.5 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 269.42 | 0.01 % | $ 41.8 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 279.36 | 0.37 % | $ 48 B | NYSE,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 328.95 | -0.32 % | $ 27.4 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |